COVID-19: Drugs with less than 60% shelf life allowed to be imported on condition - (The Economic Times via NewsPoints Desk)

  • The Central Drugs Standard Control Organisation (CDSCO) has allowed import of drugs to India with less than 60% residual shelf life on the condition that importers give an undertaking that the drug would be used or consumed before the expiry date, as reported The Economic Times on Sunday.

  • "In the light of the present situation due to the COVID-19 outbreak, the health ministry has instructed to take various steps in order to ensure availability of a sufficient quantity of drugs in the domestic retail market, besides ensuring that the product conform to be of the prescribed specification," the Drug Controller General of India (DCGI) said.

  • "One of the steps is issuing immediate approvals to applications for registration, manufacture and import of pharmaceuticals," the DCGI added.

  • "Further, we have received a representation from the industry association that there are challenges in the clearance at port offices due to the COVID-19 outbreak and many products are losing their shelf life and getting below the threshold of 60%," the DCGI said.

To read more NewsPoints articles, click here.